|
|
|
Insider
Information: |
Tyree James L |
Relationship: |
Director |
City: |
Abbott Park |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
286,780 |
|
Indirect Shares
|
1,199 |
|
|
Direct
Value |
$14,809,066 |
|
|
Indirect Value
|
$123,341 |
|
|
Total
Shares |
287,979 |
|
|
Total
Value |
$14,932,407 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-80.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Abbott Laboratories |
ABT |
Executive Vice President |
2009-02-27 |
132,176 |
2009-02-27 |
1,199 |
Premium* |
|
Innoviva Inc |
INVA |
Director |
2017-04-20 |
70,554 |
2014-06-02 |
0 |
Premium* |
|
Chemocentryx, Inc. |
CCXI |
Director |
2022-10-20 |
0 |
2015-05-22 |
0 |
Premium* |
|
Assertio Holdings Inc |
ASRT |
Director |
2019-05-08 |
80,590 |
2019-05-07 |
0 |
Premium* |
|
Genelux Corp |
GNLX |
Director |
2023-12-13 |
3,460 |
2023-02-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ABT |
Abbott Laboratories |
Senior Vice President |
|
2007-02-17 |
4 |
D |
$52.49 |
$182,980 |
D/D |
(3,486) |
119,519 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2022-06-09 |
4 |
AS |
$25.65 |
$99,129 |
D/D |
(3,863) |
19,138 |
0 |
% |
|
ABT |
Abbott Laboratories |
Senior Vice President |
|
2007-06-30 |
4 |
D |
$53.55 |
$211,255 |
D/D |
(3,945) |
102,652 |
0 |
- |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2008-08-26 |
4 |
D |
$57.76 |
$239,415 |
D/D |
(4,145) |
121,958 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2021-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,660 |
17,729 |
0 |
- |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2008-08-26 |
4 |
OE |
$45.45 |
$216,291 |
D/D |
4,759 |
126,103 |
0 |
- |
|
ABT |
Abbott Laboratories |
Senior Vice President |
|
2007-02-15 |
4 |
D |
$52.70 |
$277,202 |
D/D |
(5,260) |
87,105 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2016-05-23 |
4 |
AS |
$4.39 |
$24,337 |
D/D |
(5,544) |
20,575 |
0 |
- |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2009-02-17 |
4 |
S |
$54.09 |
$301,030 |
D/D |
(5,565) |
103,643 |
0 |
- |
|
INVA |
Innoviva Inc |
Director |
|
2014-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
21,670 |
0 |
- |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2009-02-27 |
4 |
D |
$50.58 |
$344,602 |
D/D |
(6,813) |
142,630 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2020-05-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,724 |
13,069 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2022-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,726 |
23,001 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2019-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,421 |
35,345 |
0 |
- |
|
GNLX |
Genelux Corp |
Director |
|
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
9,000 |
0 |
- |
|
GNLX |
Genelux Corp |
Director |
|
2023-12-13 |
4 |
S |
$12.91 |
$118,969 |
D/D |
(9,000) |
3,460 |
0 |
% |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2022-10-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,138) |
0 |
0 |
- |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2007-08-27 |
4 |
A |
$52.14 |
$490,116 |
D/D |
9,400 |
116,708 |
0 |
- |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2007-08-27 |
4 |
D |
$52.53 |
$510,171 |
D/D |
(9,712) |
107,308 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2022-08-04 |
4 |
AS |
$50.22 |
$502,200 |
D/D |
(10,000) |
9,138 |
0 |
% |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2008-03-04 |
4 |
S |
$52.90 |
$535,486 |
D/D |
(10,096) |
118,016 |
0 |
- |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2009-02-27 |
4 |
S |
$47.67 |
$498,458 |
D/D |
(10,454) |
132,176 |
0 |
- |
|
ABT |
Abbott Laboratories |
Senior Vice President |
|
2006-02-14 |
4 |
D |
$42.83 |
$458,153 |
D/D |
(10,697) |
68,541 |
|
- |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2008-02-25 |
4 |
D |
$54.54 |
$592,086 |
D/D |
(10,856) |
145,433 |
0 |
- |
|
ABT |
Abbott Laboratories |
Executive Vice President |
|
2007-08-27 |
4 |
OE |
$41.95 |
$464,009 |
D/D |
11,061 |
117,020 |
0 |
- |
|
89 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|